VEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France.
about
Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infectionsAcinetobacter baumannii: evolution of antimicrobial resistance-treatment optionsAntimicrobial resistance in Acinetobacter baumannii: From bench to bedsideBiology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment OptionsGES extended-spectrum β-lactamases in Acinetobacter baumannii isolates in Belgium.Integrase-mediated recombination of the veb1 gene cassette encoding an extended-spectrum β-lactamase.Molecular epidemiology of carbapenem non-susceptible Acinetobacter baumannii in France.Acinetobacter baumannii: emergence of a successful pathogenThe Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace.Multidrug-resistant Acinetobacter baumannii Harboring OXA-24 carbapenemase, SpainGlobal challenge of multidrug-resistant Acinetobacter baumanniiApplication of a microsphere-based array for rapid identification of Acinetobacter spp. with distinct antimicrobial susceptibilities.Acinetobacter baumannii: An Emerging and Important Pathogen.Neonatal infections with multidrug-resistant ESBL-producing E. cloacae and K. pneumoniae in Neonatal Units of two different Hospitals in Antananarivo, Madagascar.Incidence of healthcare associated infection in the surgical ICU of a tertiary care hospital.Distribution and Classification of Serine β-Lactamases in Brazilian Hospital Sewage and Other Environmental Metagenomes Deposited in Public Databases.VEB-1 extended-spectrum β-lactamase-producing multidrug-resistant Proteus mirabilis sepsis outbreak in a neonatal intensive care unit in India: clinical and diagnostic implications.Changes in the incidences of multidrug-resistant and extensively drug-resistant organisms isolated in a military medical center.Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak.Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance.Genetic basis of antibiotic resistance in pathogenic Acinetobacter species.Acinetobacter: a potential reservoir and dispenser for β-lactamases.Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art.Combination therapy in severe Acinetobacter baumannii infections: an update on the evidence to date.Current molecular methods in epidemiological typing of Acinetobacter baumannii.Diversity of clavulanic acid-inhibited extended-spectrum β-lactamases in Aeromonas spp. from the Seine River, Paris, France.ISCR2, another vehicle for bla(VEB) gene acquisition.NDM-1-producing Acinetobacter baumannii from Algeria.Multidrug-resistant Acinetobacter baumannii, Russia.Variable number tandem repeat loci providing discrimination within widespread genotypes of Acinetobacter baumannii.Investigation of Acinetobacter baumannii resistance to carbapenems in Marseille hospitals, south of France: a transition from an epidemic to an endemic situation.A Novel Antimicrobial Coating Represses Biofilm and Virulence-Related Genes in Methicillin-Resistant Staphylococcus aureus.
P2860
Q26991886-CC7C524A-3BBE-48E5-A4D4-5CE4391F0BD7Q27015109-46C71347-3ACE-46C6-AAA1-AB56D7704DF1Q27024893-4D69798A-AD11-4286-AD6B-6EB27CC80D8CQ30235064-1AA6D9E8-9732-48FA-BC77-C57C862ACB77Q34290202-5929D947-13D2-48A0-8A13-39639667DD76Q34516983-899FA5B4-C8B7-47FF-ACBA-3224EE77569BQ34724617-658A343E-4B09-496B-9CEF-7FC45D9A8764Q34795807-1DAE35E1-7452-420C-A5D6-3349037A9B1AQ35905605-5BF55B29-A4B4-4943-9842-6F1D86A99F1CQ35980042-2CA8CD39-2E9D-4127-915F-31C8094274A2Q36095081-A579AD4F-E970-4231-8DB3-E7C03715F3E4Q36452586-63A7AF29-40AC-4573-AC41-90B2E44ACC25Q36664292-4480DC82-D93B-44A7-A4FF-CF40B5AC8210Q36994466-BA06DF6C-BDAE-4486-BF2A-F9B1E2242DAFQ37391082-6B1FA8A8-D3F9-4369-8E1A-8C5C85CFAC22Q37413711-5FE2FCD3-DFA6-48B6-9EC5-BD6844FC1C0AQ37671577-C02C8FB7-EEE3-4F6A-9897-57B51EC5983AQ37760510-8B8F347B-D606-473D-ABAE-8D6DB306EE26Q37780543-595D1127-E869-474B-8C18-E260FE0C7B75Q37869910-F81B7BB0-2754-42CA-A36F-10AC8C188DC4Q37944605-CBE436BF-E929-4E77-A6F8-00D53FB99672Q37946953-13CC842C-8B02-443D-84F6-59EF288F98BCQ38113258-EFEC712C-96C2-4CE2-BA0C-EA501610D210Q38232199-32E8E00A-28CB-450E-B736-321E2EE70C67Q38269147-BA17FDDA-7DB6-43DE-85BC-7B71F7C2ED08Q41837614-5A632FA4-8FFB-4182-9517-8A285FEF8A2DQ42111528-77A79C0A-D262-4D96-8635-799F778B355CQ42559070-0392A3BC-CEEA-4720-8ECD-1D68B1732119Q42713089-3A91CA36-D736-403A-B161-7733B1598C15Q44410259-9A1A1A4E-88C5-4C9A-8373-EB8B18868CD8Q46919961-A6CDBF0B-1AB6-46B0-B6F8-4E8F43031637Q50351209-5C79AA87-6C31-440A-8B6D-751B51D77E09
P2860
VEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
VEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France.
@ast
VEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France.
@en
type
label
VEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France.
@ast
VEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France.
@en
prefLabel
VEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France.
@ast
VEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France.
@en
P2093
P2860
P50
P356
P1476
VEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France.
@en
P2093
Anne Carbonne
Bruno Coignard
Claude Bernet
French Nosocomial Infection Early Warning Investigation and Surveillance Network
Karine Blanckaert
Odile Bajolet
Pascal Astagneau
Xavier Verdeil
P2860
P304
P356
10.3201/EID1708.051547
P577
2006-08-01T00:00:00Z